A blood-based biomarker assay for multiple sclerosis (MS) disease activity provides actionable insights that supplement standard MS evaluations, especially for treatment initiation and de-escalation ...

A new University of Toronto-led study has discovered a possible biomarker linked to multiple sclerosis (MS) disease progression that could help identify patients most likely to benefit from new drugs.

"We were surprised that a higher proportion of life was associated with a higher risk of incident multiple sclerosis in immigrants because multiple sclerosis is often thought to be a predominant ...

Mendelian randomization revealed a significant link between higher genetically-determined BMI and increased MS severity, strengthening previous observational findings. Expanded analysis included ...

Disability progression independent of relapse activity (PIRA) -- sometimes referred to as silent progression -- is a key integrating concept in the contemporary view of multiple sclerosis (MS). "The ...

In a study of commonly used treatments for multiple sclerosis, both medical and behavioral interventions, and a combination of the two, resulted in significant improvements in fatigue. Researchers say ...